MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial
Clinical trial NCT03287427 · COMPLETED
Trial details
- NCT number
- NCT03287427
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-22
- Primary completion
- 2022-12-14
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.